|
End-of-day quote
Nasdaq
2026-08-14
|
5-day change | 1st Jan Change | ||
| 1.350 USD | 0.00% |
|
+3.05% | -28.19% |
| 06-15 | Waldencast plc Announces Fda Approval of Obagi Saypha Chiq Injectable Hyaluronic Acid Gel | CI |
| 06-15 | Waldencast Says US FDA Approves Obagi Saypha ChIQ Injectable Hyaluronic Acid Gel | MT |
Chart: Technical Analysis
Stock exchange
Nasdaq
WALD 1.350 $
0.00%
126K
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq
| WALD | 1.370USD | +0.74% | 315K $ | |
Nasdaq
| WALD | 1.350USD | 0.00% | 126K $ | |
CBOE
| WALD | 1.360USD | -0.73% | 6.57K $ |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bullish | Neutral |
| Resistance | 1.56 | 1.87 | 3.08 |
| Spread/Res. | -13.46% | -27.81% | -56.17% |
| Spread/Supp. | +9.76% | +9.76% | +58.54% |
| Support | 1.23 | 1.23 | 0.8515 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- WALD Stock
- Charts Waldencast plc
Select your edition
All financial news and data tailored to specific country editions
